Cahill Represents Lead Arrangers in $3.48 Billion Credit Facility for Bausch Health Companies Inc., and Bausch Health Americas Inc.
Date: 05/10/22
Cahill represented the lead arrangers in connection with a Refinancing Amendment establishing a $2,500,000,000 term B credit facility and a $975,000,000 revolving credit facility for Bausch Health Companies Inc. and Bausch Health Americas, Inc. Proceeds from the credit facilities will be used for general corporate purposes and refinancing existing credit facilities. Bausch Health Companies Inc. is a global, diversified pharmaceutical company.